Skip to main content

NAD refers Colotox ad claims to FDA

2/11/2009

NEW YORK The National Advertising Division of the Council of Better Business Bureaus on Monday referred the advertising claims of Central Coast Nutraceuticals’ regarding “Colotox” to both the Federal Trade Commission and the Food and Drug Administration for further review after Central Coast failed to respond to an NAD inquiry.

According to NAD, Colotox is marketed as a colon cleanser and implies that the product can be used in the prevention of colon cancer.

NAD requested substantiation for express claims, including that  Colotox will help to/with:

  • Remove toxic buildup 
  • Increase your energy levels 
  • Cleanse your entire system 
  • Decrease gas and bloating 
  • Reduce water retention 
  • Detoxify your organs 
  • Give you radiant hair, skin and nails 
  • Bad breath
  • Lose excess weight

Also, that Colotox could be used in relief of thise ailments:

  • Chronic fatigue  
  • Low energy levels  
  • Constipation  
  • Bloating  
  • Bad breath  
  • Detoxify your organs  
  • Excess weight you just can’t seem to lose

NAD also requested substantiation for the implied claims related to colon-cancer prevention, including: 

  • Colon cancer is currently the second leading cancer killer in the United States, with 60,000 Americans expected to die from the disease this year. 
  • “An estimated 150,000 people in America will be diagnosed with colorectal cancer this year, and while progress is being made to prevent and treat the disease, tragically more than 57,000 will die from it
  • “Colon cancer is one of the deadliest diseases to affect Americans”
  • “The Early Show medical correspondent Dr. Emily Senay reports that an average of 57,000 Americans die each year from colon cancer”
  • “When colon cancer is caught late, it is survivable only 8% of the time”

NAD, which made several attempts to contact the advertiser, noted that it was disappointed the advertiser did not respond to the NAD’s inquiry, “especially in light of the strong health-related and weight-loss claims being made in the advertising. Pursuant to its procedures, NAD has referred the matter to the appropriate federal agencies. 

X
This ad will auto-close in 10 seconds